Gordonibacter pamelaeae based Microbiome Therapeutic Research Service
In the rapidly evolving landscape of Live Biotherapeutic Products (LBPs), Gordonibacter pamelaeae has emerged as a cornerstone species for metabolic and anti-inflammatory research. As a key member of the human gut microbiota capable of transforming dietary polyphenols into bioactive metabolites, this strain represents a bridge between nutrition, microbial ecology, and systemic health.
The complexity of the human microbiome requires more than just standard laboratory techniques; it demands a deep understanding of anaerobic physiology and the intricate chemical signaling between microbes and host cells. Our Gordonibacter pamelaeae-based Microbiome Therapeutic Research Service is designed to empower pharmaceutical and biotech innovators with high-precision tools, specialized anaerobic expertise, and validated preclinical models. By focusing on the unique metabolic niche of the Eggerthellaceae family, we provide the necessary infrastructure to translate this strain's unique potential into transformative clinical therapies that address the root causes of chronic disease.
Overview: The Gatekeeper of Urolithin Metabolism
Gordonibacter pamelaeae is a Gram-positive, obligately anaerobic, non-spore-forming bacterium belonging to the Eggerthellaceae family. Originally isolated from the human colon, it occupies a specialized niche in the gut microbiome.
Unlike many commensal bacteria, G. pamelaeae possesses a rare enzymatic repertoire capable of dehydroxylating ellagic acid (EA) and ellagitannins. This process converts poorly absorbed dietary compounds into Urolithin C, a precursor to the highly bioavailable and anti-inflammatory Urolithin A. Beyond polyphenol metabolism, recent research highlights its role in the 21-dehydroxylation of glucocorticoids, producing neuroactive progestins that influence the gut-brain axis.
Our Preclinical Research Services
Navigating the complexities of anaerobic microbiology requires specialized equipment and protocols. We offer a full-spectrum service suite to accelerate your G. pamelaeae research.
Microbiological & Genomic Services
Strain Characterization: We provide high-resolution phenotypic and genotypic profiling, including Whole Genome Sequencing (WGS) to identify Antibiotic Resistance Genes (ARGs) and virulence factors, ensuring regulatory safety compliance.
Custom Isolation: If your project requires a specific isolate from a unique cohort (e.g., centenarians or elite athletes), our team can perform targeted isolation using selective media and anaerobic "picking" technologies.
Fermentation Optimization: G. pamelaeae is fastidious. We optimize nitrogen sources, carbon sources, and redox potential in 5L to 50L bioreactors to achieve high biomass yields for downstream testing.
Urolithin Conversion Assays: We quantify the efficiency of your strain's ability to convert ellagic acid into Urolithins using validated LC-MS/MS methods.
Enzyme Kinetics: Analysis of the dehydroxylase enzymes responsible for polyphenol transformation.
Serum/Fecal Analysis: Tracking metabolite concentrations in animal models to determine bioavailability and pharmacokinetics.
Organ-on-a-Chip: Utilizing gut-on-a-chip technology to observe the interaction between G. pamelaeae and human intestinal epithelial cells under flow conditions.
Anaerobic Co-culture: We utilize the similar multi-stage fermenters to study how G. pamelaeae interacts with a complex human fecal microbiota.
Gnotobiotic Animal Models: We maintain a colony of germ-free mice that can be colonized solely with G. pamelaeae or a defined consortium to study its effects in isolation.
Disease-Specific Models:
DSS/TNBS-induced Colitis: To test anti-inflammatory potential.
High-Fat Diet (HFD) Models: To test metabolic and weight-management claims.
APP/PS1 Mouse Models: For Alzheimer's research involving mitochondrial health.
Our Product Offerings
For researchers who require high-quality biological materials for in-house studies, we offer:
This product contains high-quality, intact genomic DNA isolated from Gordonibacter pamelaeae Genomic DNA. It is a purified and ready-to-use DNA sample, ideal for a wide range of molecular biology applications, including PCR, qPCR, and Next-Generation Sequencing.
Research Applications: From Metabolic Health to Longevity
As a specialized CRO, we track the cutting edge of microbiome science to ensure our services align with current therapeutic trends. Gordonibacter pamelaeae is currently being researched across several high-impact fields:
Through the production of urolithins, G. pamelaeae strengthens the intestinal barrier by upregulating tight junction proteins. It significantly reduces the expression of pro-inflammatory cytokines like TNF-α and IL-6, mitigating the mucosal damage associated with Crohn's disease and ulcerative colitis.
Urolithin metabolites produced by G. pamelaeae exhibit antiproliferative effects by inhibiting the Wnt signaling pathway and inducing apoptosis in malignant cells. It is also being studied for its ability to enhance the efficacy of immune checkpoint inhibitors (ICIs).
By producing neuroactive steroids (such as allopregnanolone) and anti-inflammatory urolithins, G. pamelaeae helps protect against neuroinflammation. Research is ongoing regarding its potential to slow the progression of Alzheimer's and Parkinson's diseases by reducing oxidative stress in the central nervous system.
Urolithins produced by this strain reduce lipid accumulation and improve mitochondrial function (mitophagy). High abundances of Gordonibacter species have been correlated with the microbiome profiles of centenarians, suggesting a role in healthy aging and systemic inflammation control (inflammaging).
Our Advantages: Why Partner With Us?
Anaerobic Excellence
We operate state-of-the-art anaerobic chambers and fermentation suites specifically calibrated for the delicate requirements of G. pamelaeae.
Deep Domain Expertise
Our scientific team consists of PhDs specializing in the Eggerthellaceae family and polyphenol metabolism.
Integrated Workflow
We combine microbial culturing with advanced metabolomics and histopathology, providing a holistic view of your therapeutic candidate.
Regulatory Readiness
Our preclinical data packages are designed to meet international standards for Live Biotherapeutic Product (LBP) filings.
Multi-Omics Integration
We correlate 16S/Metagenomic data with targeted metabolomics and host transcriptomics to provide a 360-degree view of the strain's impact.
Join the Revolution in Microbiome Medicine
The transition from broad-spectrum probiotics to precision microbiome therapeutics is well underway. Gordonibacter pamelaeae stands at the forefront of this shift, offering a unique opportunity to modulate human health through the precision engineering of microbial metabolism.
As a leader in preclinical LBP research, our company is committed to lowering the barriers to entry for researchers in this field. Whether you are exploring the anti-aging properties of Urolithin A or developing a novel treatment for metabolic syndrome, we provide the scientific rigor and technical infrastructure to turn your vision into a reality. Let us partner to unlock the full therapeutic potential of the human microbiome.
Is Gordonibacter pamelaeae considered a probiotic?
While it shows significant health benefits, it is currently classified as a "Next-Generation Probiotic" (NGP) or a candidate for a Live Biotherapeutic Product (LBP) in clinical contexts.
How do you ensure the stability of the strain during shipping?
We utilize specialized lyophilization (freeze-drying) protocols and oxygen-scavenging packaging to ensure maximum CFU viability upon arrival.
Can you perform co-culture studies with other gut microbes?
Yes. Since the conversion of Urolithins often requires a microbial consortium, we offer co-culture services with Enterocloster species and other commensals to simulate the human gut environment.
What is the primary challenge in working with this strain?
Its strict anaerobic nature and slow growth rate require specialized equipment and expertise in anaerobic microbiology to maintain viability and metabolic activity.
Online Inquiry
For Research Use Only. Not intended for use in
food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
